OPT Industries, a manufacturing technology startup, opened a 14,000-square-foot manufacturing facility in Medford, Massachusetts.
The location will help the company scale market access to RAMPTM, the first roll-to-roll 3D printing platform that allows continuous materials production at unlimited lengths with new levels of micron-level precision.
"Our proprietary additive manufacturing system specializes in making microstructures at a massive scale," said OPT founder Jifei Ou. "We're unique in precision microfabrication that can create rolls of materials and designs with no limitation in length. Our technology stack currently provides material solutions for medical, cosmetic, and consumer product applications."
According to company officials, the technology enables 24/7 fully automated production of continuous 3D printed microstructures with no limitation in length. During the pandemic, the team quickly scaled up the technology to design and manufacture the InstaSwabTM novel nasal swab for COVID-19 testing. To date, OPT has supplied over 800,000 swabs to a number of healthcare and at-home testing organizations nationwide.
"New and emerging technology industries recognize that Medford is an ideal place to start a business and access our incredible talent pool, robust City resources and top level restaurants and shops," said Mayor Breanna Lungo-Koehn. "I am thrilled that OPT Industries is choosing to call Medford home and it was an honor to cut the ribbon on their new headquarters in the City. This innovative company is hard at work perfecting a revolutionary 3D-printed nasal swab that can detect trace amounts of the COVID-19 virus, enabling people to get diagnosed and treated faster."
As a fully equipped research lab and manufacturing site, the 14,000-square-foot facility adheres to Good Manufacturing Practice (GMP) guidelines and ISO 13485:2016-certification for medical device manufacturing. Amid growing demand by Fortune 500 companies and market leaders for OPT's products, including the InstaSwabTM high efficacy medical swab, OPT is establishing its first product line focused on serving the medical sector.
The location will help the company scale market access to RAMPTM, the first roll-to-roll 3D printing platform that allows continuous materials production at unlimited lengths with new levels of micron-level precision.
"Our proprietary additive manufacturing system specializes in making microstructures at a massive scale," said OPT founder Jifei Ou. "We're unique in precision microfabrication that can create rolls of materials and designs with no limitation in length. Our technology stack currently provides material solutions for medical, cosmetic, and consumer product applications."
According to company officials, the technology enables 24/7 fully automated production of continuous 3D printed microstructures with no limitation in length. During the pandemic, the team quickly scaled up the technology to design and manufacture the InstaSwabTM novel nasal swab for COVID-19 testing. To date, OPT has supplied over 800,000 swabs to a number of healthcare and at-home testing organizations nationwide.
"New and emerging technology industries recognize that Medford is an ideal place to start a business and access our incredible talent pool, robust City resources and top level restaurants and shops," said Mayor Breanna Lungo-Koehn. "I am thrilled that OPT Industries is choosing to call Medford home and it was an honor to cut the ribbon on their new headquarters in the City. This innovative company is hard at work perfecting a revolutionary 3D-printed nasal swab that can detect trace amounts of the COVID-19 virus, enabling people to get diagnosed and treated faster."
As a fully equipped research lab and manufacturing site, the 14,000-square-foot facility adheres to Good Manufacturing Practice (GMP) guidelines and ISO 13485:2016-certification for medical device manufacturing. Amid growing demand by Fortune 500 companies and market leaders for OPT's products, including the InstaSwabTM high efficacy medical swab, OPT is establishing its first product line focused on serving the medical sector.